| |
| |
|
| Insider
Information: |
Zalevsky Jonathan |
| Relationship: |
|
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
265,025 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$386,937 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
265,025 |
|
|
| Total
Value |
$386,937 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nektar Therapeutics |
NKTR |
|
2024-02-20 |
265,025 |
2019-10-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2024-02-20 |
4 |
S |
$0.68 |
$6,130 |
D/D |
(9,014) |
265,025 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2023-11-17 |
4 |
S |
$0.49 |
$4,727 |
D/D |
(9,646) |
274,039 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2023-08-16 |
4 |
S |
$0.78 |
$7,568 |
D/D |
(9,703) |
283,685 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2023-05-16 |
4 |
S |
$0.72 |
$7,050 |
D/D |
(9,791) |
293,388 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2023-02-16 |
4 |
S |
$3.00 |
$31,452 |
D/D |
(10,484) |
303,179 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2022-11-16 |
4 |
S |
$3.57 |
$48,052 |
D/D |
(13,460) |
313,663 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2022-08-18 |
4 |
AS |
$4.65 |
$342,779 |
D/D |
(73,716) |
327,123 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2022-08-16 |
4 |
S |
$4.76 |
$50,266 |
D/D |
(10,560) |
400,839 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2022-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
135,000 |
411,399 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2022-05-16 |
4 |
S |
$3.95 |
$85,608 |
D/D |
(21,673) |
276,399 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2022-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
23,950 |
298,072 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2022-02-16 |
4 |
S |
$10.95 |
$119,486 |
D/D |
(10,912) |
274,122 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2021-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
52,950 |
285,034 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2021-11-16 |
4 |
S |
$13.16 |
$274,636 |
D/D |
(20,869) |
232,084 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2021-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
40,150 |
252,953 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2021-08-16 |
4 |
S |
$13.83 |
$105,965 |
D/D |
(7,662) |
212,803 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2021-05-17 |
4 |
S |
$18.30 |
$569,331 |
D/D |
(31,111) |
235,065 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2021-02-16 |
4 |
S |
$22.37 |
$540,034 |
D/D |
(24,141) |
266,176 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2020-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
290,317 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2020-11-23 |
4 |
AS |
$16.40 |
$268,632 |
D/D |
(16,380) |
250,317 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2020-11-16 |
4 |
S |
$16.93 |
$501,433 |
D/D |
(29,618) |
266,697 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2020-08-17 |
4 |
S |
$19.67 |
$515,354 |
D/D |
(26,200) |
296,315 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2020-05-18 |
4 |
S |
$22.51 |
$102,601 |
D/D |
(4,558) |
322,515 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2020-02-18 |
4 |
S |
$22.35 |
$106,699 |
D/D |
(4,774) |
327,073 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Chief R&D Officer |
• – – |
2019-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
40,150 |
331,847 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
